Want to join the conversation?
$HAR 4Q15 PR: Net sales grew 16% YoverY to $1.68Bil and FY15 net sales was up 15% YoverY to $6.16Bil. GAAP net income was $73.64MM or $1.01 per diluted share and FY15 GAAP net income totaled $342.99MM or $4.84 per diluted share. Over last 2 years, HAR has achieved outstanding growth; added nearly $2Bil in revenue and increased non-GAAP EPS by 86%.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)